Adagene Inc. (ADAG) stock
ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.48−0.12 (-7.50%)
Close on Nov 17, 2026Market cap $87.66MP/E –Yield –
Adagene cash
Cash and short-term investments held at the end of each period.
Adagene's cash was $127.91M at Jun 30, 2026. For fiscal 2025 it was $74.52M, down 12.5% from the year before. The highest annual figure on record is $174.39M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $74.52M | -12.5% |
| FY2024 | Dec 31, 2024 | $85.19M | -22.5% |
| FY2023 | Dec 31, 2023 | $109.93M | -23.5% |
| FY2022 | Dec 31, 2022 | $143.76M | -17.6% |
| FY2021 | Dec 31, 2021 | $174.39M | +132.1% |
| FY2020 | Dec 31, 2020 | $75.15M | -25.2% |
| FY2019 | Dec 31, 2019 | $100.53M | +526.0% |
| FY2018 | Dec 31, 2018 | $16.06M | +83.8% |
| FY2017 | Dec 31, 2017 | $8.74M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $127.91M | +33.7% |
| Q4 FY2025 | Dec 31, 2025 | $74.52M | -32.2% |
| Q2 FY2025 | Jun 30, 2025 | $62.83M | -51.2% |
| Q4 FY2024 | Dec 31, 2024 | $85.19M | -40.7% |
| Q2 FY2024 | Jun 30, 2024 | $95.67M | -45.1% |
| Q4 FY2023 | Dec 31, 2023 | $109.93M | +46.3% |
| Q2 FY2023 | Jun 30, 2023 | $128.76M | +28.1% |
| Q4 FY2022 | Dec 31, 2022 | $143.76M | +795.2% |
| Q4 FY2021 | Dec 31, 2021 | $174.39M | +1896.2% |
| Q4 FY2020 | Dec 31, 2020 | $75.15M | – |
| Q4 FY2019 | Dec 31, 2019 | $100.53M | – |
| Q4 FY2018 | Dec 31, 2018 | $16.06M | – |
| Q4 FY2017 | Dec 31, 2017 | $8.74M | – |
See a number that looks wrong?